NCM
ENFN

Nellore Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Nellore Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-868,085
Closed -$9.68M – 17
2025
Q1 		$9.68M Hold
868,085
– – 1.32% 11
2024
Q4 		$8.94M Sell
868,085
-1,208,883
-58% -$11.7M 1.17% 12
2024
Q3 		$19.4M Buy
2,076,968
+277,672
+15% +$2.4M 2.64% 11
2024
Q2 		$15.3M Buy
1,799,296
+420,993
+31% +$3.85M 2.31% 12
2024
Q1 		$12.7M Buy
1,378,303
+270,543
+24% +$2.38M 1.97% 12
2023
Q4 		$10.7M Buy
1,107,760
+607,016
+121% +$5.67M 1.98% 10
2023
Q3 		$4.49M Buy
500,744
+135,479
+37% +$1.29M 0.84% 11
2023
Q2 		$4.1M Buy
+365,265
New +$3.24M 0.77% 11
2022
Q2 		– Sell
-210,521
Closed -$2.68M – 24
2022
Q1 		$2.68M Buy
210,521
+160,521
+321% +$2.45M 0.61% 18
2021
Q4 		$1.05M Buy
+50,000
New +$1.01M 0.28% 21

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nellore Capital Management's ENFN Position: Q2 2025 in Review

Nellore Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 868,085 shares — an estimated $9.68M sold.

Nellore Capital Management first reported a position in ENFN in Q4 2021 and held it in 10 quarters. The position peaked at $19.4M in Q3 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Nellore Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Nellore Capital Management sold 868,085 Enfusion, Inc. shares in Q2 2025, an estimated $9.68M.
  • Nellore Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 10 quarters.
  • Nellore Capital Management's Enfusion, Inc. position peaked at $19.4M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Nellore Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.